These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. Eur Urol Oncol; 2023 Oct; 6(5):501-507. PubMed ID: 36868922 [Abstract] [Full Text] [Related]
28. External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era. Frego N, Paciotti M, Buffi NM, Maffei D, Contieri R, Avolio PP, Fasulo V, Uleri A, Lazzeri M, Hurle R, Saita A, Guazzoni GF, Casale P, Lughezzani G. Front Surg; 2022 Oct; 9():829515. PubMed ID: 35284478 [Abstract] [Full Text] [Related]
29. Development of a novel nomogram incorporating platelet-to-lymphocyte ratio for the prediction of lymph node involvement in prostate carcinoma. Merhe A, Labban M, Hout M, Bustros G, Abou Heidar N, El-Asmar JM, Bulbul M, El Hajj A. Urol Oncol; 2020 Dec; 38(12):930.e1-930.e6. PubMed ID: 32736935 [Abstract] [Full Text] [Related]
30. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms. Lodeta B, Baric H, Hatz D, Jozipovic D, Augustin H. BMC Urol; 2023 Nov 18; 23(1):190. PubMed ID: 37980520 [Abstract] [Full Text] [Related]
33. Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold. Venclovas Z, Muilwijk T, Matjosaitis AJ, Jievaltas M, Joniau S, Milonas D. J Clin Med; 2021 Mar 02; 10(5):. PubMed ID: 33801231 [Abstract] [Full Text] [Related]
35. First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy. Bandini M, Marchioni M, Pompe RS, Tian Z, Gandaglia G, Fossati N, Abdollah F, Graefen M, Montorsi F, Saad F, Shariat SF, Briganti A, Karakiewicz PI. BJU Int; 2018 Apr 02; 121(4):592-599. PubMed ID: 29124911 [Abstract] [Full Text] [Related]
37. 68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer. Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Rupp NJ, Huellner M, Messerli M, Rüschoff JH, Ter Voert EEGW, Hermanns T, Burger IA. Eur J Nucl Med Mol Imaging; 2020 Jan 02; 47(1):147-159. PubMed ID: 31522272 [Abstract] [Full Text] [Related]
38. Pelvic lymph node dissection in prostate cancer. Briganti A, Blute ML, Eastham JH, Graefen M, Heidenreich A, Karnes JR, Montorsi F, Studer UE. Eur Urol; 2009 Jun 02; 55(6):1251-65. PubMed ID: 19297079 [Abstract] [Full Text] [Related]
39. Modelling Study with an Interactive Model Assessing the Cost-effectiveness of 68Ga Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Nano Magnetic Resonance Imaging for the Detection of Pelvic Lymph Node Metastases in Patients with Primary Prostate Cancer. Scholte M, Barentsz JO, Sedelaar JPM, Gotthardt M, Grutters JPC, Rovers MM. Eur Urol Focus; 2020 Sep 15; 6(5):967-974. PubMed ID: 30826284 [Abstract] [Full Text] [Related]
40. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer. Pellegrino F, Mazzone E, Stabile A, Beauval JB, Marra G, Campi R, Afferi L, Zhuang J, Sorce G, Rosiello G, Barletta F, Scuderi S, Guo H, Gontero P, Minervini A, Ploussard G, Montorsi F, Briganti A, Gandaglia G. Urol Oncol; 2023 Sep 15; 41(9):387.e17-387.e25. PubMed ID: 37198026 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]